Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1888305-96-1

Post Buying Request

1888305-96-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1888305-96-1 Usage

General Description

"4-(2-bromo-6-fluorobenzoyl)-N-(pyridin-3-yl)-1H-pyrrole-2-carboxamide" is a compound with a complex chemical structure. It contains a pyrrole ring with a carboxamide group attached, as well as a benzoyl group with bromine and fluorine substituents. Additionally, a pyridine ring is also present in the molecule. 4-(2-bromo-6-fluorobenzoyl)-N-(pyridin-3-yl)-1H-pyrrole-2-carboxamide may have potential applications in pharmaceuticals or materials science due to its unique structure and properties. Further research is needed to fully understand the potential uses and effects of this chemical.

Check Digit Verification of cas no

The CAS Registry Mumber 1888305-96-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,8,8,3,0 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1888305-96:
(9*1)+(8*8)+(7*8)+(6*8)+(5*3)+(4*0)+(3*5)+(2*9)+(1*6)=231
231 % 10 = 1
So 1888305-96-1 is a valid CAS Registry Number.

1888305-96-1Downstream Products

1888305-96-1Relevant articles and documents

Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4

Myers, Stephanie M.,Miller, Duncan C.,Molyneux, Lauren,Arasta, Mercedes,Bawn, Ruth H.,Blackburn, Timothy J.,Cook, Simon J.,Edwards, Noel,Endicott, Jane A.,Golding, Bernard T.,Griffin, Roger J.,Hammonds, Tim,Hardcastle, Ian R.,Harnor, Suzannah J.,Heptinstall, Amy B.,Lochhead, Pamela A.,Martin, Mathew P.,Martin, Nick C.,Newell, David R.,Owen, Paul J.,Pang, Leon C.,Reuillon, Tristan,Rigoreau, Laurent J.M.,Thomas, Huw D.,Tucker, Julie A.,Wang, Lan-Zhen,Wong, Ai-Ching,Noble, Martin E.M.,Wedge, Stephen R.,Cano, Celine

, p. 530 - 543 (2019/06/19)

Extracellular regulated kinase 5 (ERK5) signalling has been implicated in driving a number of cellular phenotypes including endothelial cell angiogenesis and tumour cell motility. Novel ERK5 inhibitors were identified using high throughput screening, with

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1888305-96-1